Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Participants With Advanced Melanoma (MK-3475-002/P08719/KEYNOTE-002)
Clinical trial NCT01704287 · COMPLETED
Trial details
- NCT number
- NCT01704287
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-20
- Primary completion
- 2015-11-16
- Enrollment
- 540
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.